These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15148229)

  • 1. Photodynamic therapy for corneal neovascularisation and lipid degeneration.
    Brooks BJ; Ambati BK; Marcus DM; Ratanasit A
    Br J Ophthalmol; 2004 Jun; 88(6):840. PubMed ID: 15148229
    [No Abstract]   [Full Text] [Related]  

  • 2. Topographical alteration in the cornea after photodynamic therapy for neovascularization in lipid keratopathy.
    Igarashi T; Yaguchi C; Inage M; Suzuki H; Takahashi H
    Jpn J Ophthalmol; 2009 Nov; 53(6):655-657. PubMed ID: 20020250
    [No Abstract]   [Full Text] [Related]  

  • 3. Photodynamic therapy of corneal neovascularization with verteporfin.
    Fossarello M; Peiretti E; Zucca I; Serra A
    Cornea; 2003 Jul; 22(5):485-8. PubMed ID: 12827058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of herpes zoster related corneal neovascularisation and lipid keratopathy by photodynamic therapy.
    Goh YW; McGhee CNj; Patel DV; Barnes R; Misra S
    Clin Exp Optom; 2014 May; 97(3):274-7. PubMed ID: 24112362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photodynamic therapy with verteporfin for corneal neovascularization.
    Yoon KC; You IC; Kang IS; Im SK; Ahn JK; Park YG; Ahn KY
    Am J Ophthalmol; 2007 Sep; 144(3):390-395. PubMed ID: 17631268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Corneal neovascularisation treatments compared: Subconjunctival bevacizumab injections and/or photodynamic therapy].
    Hamdan J; Boulze M; Aziz A; Alessi G; Hoffart L
    J Fr Ophtalmol; 2015 Dec; 38(10):924-33. PubMed ID: 26522892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental inhibition of corneal neovascularization by photodynamic therapy with verteporfin.
    Yoon KC; Ahn KY; Lee SE; Kim KK; Im SK; Oh HJ; Jeong IY; Park SW; Park YG; Nah HJ; Im WB
    Curr Eye Res; 2006 Mar; 31(3):215-24. PubMed ID: 16531278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent herpes simplex keratitis after verteporfin photodynamic therapy for corneal neovascularization.
    Yoon KC; Im SK; Park HY
    Cornea; 2010 Apr; 29(4):465-7. PubMed ID: 20164757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photodynamic therapy with verteporfin for corneal neovascularization.
    Al-Torbak AA
    Middle East Afr J Ophthalmol; 2012; 19(2):185-9. PubMed ID: 22623856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photodynamic therapy with verteporfin in a rabbit model of corneal neovascularization.
    Holzer MP; Solomon KD; Vroman DT; Sandoval HP; Margaron P; Kasper TJ; Crosson CE
    Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):2954-8. PubMed ID: 12824237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neovascularization corneal regression in patients treated with photodynamic therapy with verteporfin].
    Díaz-Dávalos CD; Carrasco-Quiroz A; Rivera-Díez D
    Rev Med Inst Mex Seguro Soc; 2016; 54(2):164-9. PubMed ID: 26960043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of photodynamic therapy with verteporfin combined with intrastromal bevacizumab for corneal neovascularization in Stevens-Johnson syndrome.
    Yoon HJ; Kim MK; Seo KY; Ueta M; Yoon KC
    Int Ophthalmol; 2019 Jan; 39(1):55-62. PubMed ID: 29256167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accumulation of photosensitizer ATX-S10 (Na) in experimental corneal neovascularization.
    Gohto Y; Obana A; Kaneda K; Nakajima S; Takemura T; Miki T
    Jpn J Ophthalmol; 2000; 44(4):348-53. PubMed ID: 10974289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regression of mature lymphatic vessels in the cornea by photodynamic therapy.
    Bucher F; Bi Y; Gehlsen U; Hos D; Cursiefen C; Bock F
    Br J Ophthalmol; 2014 Mar; 98(3):391-5. PubMed ID: 24414403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of protein change and oxidative stress index after photodynamic therapy of corneal neovascularization.
    Abdelkawi SA; Hassan AA
    Gen Physiol Biophys; 2012 Dec; 31(4):449-55. PubMed ID: 23255672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photodynamic therapy with verteporfin combined with subconjunctival injection of bevacizumab for corneal neovascularization.
    You IC; Im SK; Lee SH; Yoon KC
    Cornea; 2011 Jan; 30(1):30-3. PubMed ID: 20861729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic Therapy Leads to Time-Dependent Regression of Pathologic Corneal (Lymph) Angiogenesis and Promotes High-Risk Corneal Allograft Survival.
    Hou Y; Le VNH; Clahsen T; Schneider AC; Bock F; Cursiefen C
    Invest Ophthalmol Vis Sci; 2017 Nov; 58(13):5862-5869. PubMed ID: 29145577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resolution of bilateral corneal neovascularization and lipid keratopathy after photodynamic therapy with verteporfin.
    Al-Abdullah AA; Al-Assiri A
    Optometry; 2011 Apr; 82(4):212-4. PubMed ID: 21216676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of subfoveal choroidal neovascularisation in age related macular degeneration: focus on clinical application of verteporfin photodynamic therapy.
    Soubrane G; Bressler NM
    Br J Ophthalmol; 2001 Apr; 85(4):483-95. PubMed ID: 11264143
    [No Abstract]   [Full Text] [Related]  

  • 20. Photodynamic therapy with PhotoPoint photosensitiser MV6401, indium chloride methyl pyropheophorbide, achieves selective closure of rat corneal neovascularisation and rabbit choriocapillaris.
    Ciulla TA; Criswell MH; Snyder WJ; Small W
    Br J Ophthalmol; 2005 Jan; 89(1):113-9. PubMed ID: 15615758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.